NanoVibronix Statistics
Total Valuation
NanoVibronix has a market cap or net worth of $2.47 million. The enterprise value is $5.78 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NanoVibronix has 2.58 million shares outstanding. The number of shares has increased by 98.93% in one year.
| Current Share Class | 2.58M |
| Shares Outstanding | 2.58M |
| Shares Change (YoY) | +98.93% |
| Shares Change (QoQ) | +84.42% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 5.68% |
| Float | 2.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.13 |
| Forward PS | n/a |
| PB Ratio | 0.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.47, with a Debt / Equity ratio of 0.11.
| Current Ratio | 0.47 |
| Quick Ratio | 0.12 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.67 |
Financial Efficiency
Return on equity (ROE) is -28.65% and return on invested capital (ROIC) is -14.08%.
| Return on Equity (ROE) | -28.65% |
| Return on Assets (ROA) | -12.08% |
| Return on Invested Capital (ROIC) | -14.08% |
| Return on Capital Employed (ROCE) | -13.55% |
| Revenue Per Employee | $85,871 |
| Profits Per Employee | -$181,032 |
| Employee Count | 31 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 0.63 |
Taxes
In the past 12 months, NanoVibronix has paid $27,000 in taxes.
| Income Tax | 27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.64% in the last 52 weeks. The beta is 1.76, so NanoVibronix's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | -88.64% |
| 50-Day Moving Average | 3.30 |
| 200-Day Moving Average | 5.16 |
| Relative Strength Index (RSI) | 35.42 |
| Average Volume (20 Days) | 9,596,621 |
Short Selling Information
The latest short interest is 707,054, so 27.35% of the outstanding shares have been sold short.
| Short Interest | 707,054 |
| Short Previous Month | 356,914 |
| Short % of Shares Out | 27.35% |
| Short % of Float | 27.36% |
| Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, NanoVibronix had revenue of $2.66 million and -$5.61 million in losses. Loss per share was -$15.39.
| Revenue | 2.66M |
| Gross Profit | 1.21M |
| Operating Income | -4.87M |
| Pretax Income | -3.17M |
| Net Income | -5.61M |
| EBITDA | -4.85M |
| EBIT | -4.87M |
| Loss Per Share | -$15.39 |
Full Income StatementBalance Sheet
The company has $601,000 in cash and $3.92 million in debt, giving a net cash position of -$3.32 million or -$1.28 per share.
| Cash & Cash Equivalents | 601,000 |
| Total Debt | 3.92M |
| Net Cash | -3.32M |
| Net Cash Per Share | -$1.28 |
| Equity (Book Value) | 35.68M |
| Book Value Per Share | 48.60 |
| Working Capital | -4.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.28 million and capital expenditures -$7,000, giving a free cash flow of -$3.29 million.
| Operating Cash Flow | -3.28M |
| Capital Expenditures | -7,000 |
| Free Cash Flow | -3.29M |
| FCF Per Share | -$1.27 |
Full Cash Flow StatementMargins
Gross margin is 45.57%, with operating and profit margins of -182.79% and -210.82%.
| Gross Margin | 45.57% |
| Operating Margin | -182.79% |
| Pretax Margin | -209.80% |
| Profit Margin | -210.82% |
| EBITDA Margin | -182.09% |
| EBIT Margin | -182.79% |
| FCF Margin | n/a |
Dividends & Yields
NanoVibronix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -98.93% |
| Shareholder Yield | -98.93% |
| Earnings Yield | -227.46% |
| FCF Yield | -133.23% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 14, 2025. It was a reverse split with a ratio of 0.0909091:1.
| Last Split Date | Mar 14, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0909091:1 |
Scores
NanoVibronix has an Altman Z-Score of -2.56 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.56 |
| Piotroski F-Score | 1 |